Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

Antitumor necrosis factor treatment for pediatric inflammatory bowel disease

<p class="AbstractANGClanekAbstract"><span lang="EN-US">Over the last 10 years, biologic treatment with the antitumor necrosis factor (anti-TNF) antibodies has dramatically changed the therapeutic approach in pediatric patients with inflammatory bowel disease (IBD). C...

Full description

Bibliographic Details
Main Authors: Darja Urlep, Vojislav N. Perisic, Rok Orel
Format: Article
Language:English
Published: Slovenian Medical Association 2013-10-01
Series:Zdravniški Vestnik
Subjects:
pediatric inflammatory bowel disease
treatment
anti-TNF agents
infliximab
adalimumab
Online Access:http://vestnik.szd.si/index.php/ZdravVest/article/view/692

Similar Items

Similar Items